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The mouse mammary gland may undergo cycles of proliferation,terminal differentiation,tissue remodeling,and more importantly
malignanttransformation.Mammaryepithelialstemcellsandtheirprogenyparticipateintheseprocesses.Mammaryepithelialstem
cells are multipotent, exhibit properties of self renewal (up to 7 divisions) and may exist either as long-lived nondividing cells or as
proliferating-differentiating cells. The focus of this study was to locate stem cells by identifying them as long-lived, label-retaining
mammary epithelial cells (LRCs) in growth active (developing) or growth static (aged) mammary ducts. Initially,primary epithelial
cells were pulse labeled with either ﬂuorescent tracker dye and/or BrdU. Cells were then transplanted into cleared juvenile syngeneic
mammary fat pads and held for 5weeks or 8weeks. In this study, we demonstrate that LRCs are stem cells and their progeny
(transitional cells) are arranged as transitional units (TUs). Additionally, TUs are located every 250 ± 75µm in ducts or in the
terminal end bud 200–600µm in diameter. Molecules expressed in TUs were Zonula Occludens-1 and α-catenin proteins which
were signiﬁcantly detected in 75%–91% (P<0.001) of the LRCs cells that make up the TU. These data suggest that transitional
units may be a group of label-retaining stem cells and maybe involved in the developmental or cancer process.
INTRODUCTION
One of the most interesting features of the mammary
gland is the capacity to maintain an abundant supply of self
renewing, undifferentiated stem cells [1–6]. Mammary epi-
thelialstemcellsarebelievablythetargetsforthedevelopment
of breast cancer.As reviewed by Potten and Loefﬂer [7],stem
cells are long-lived undifferentiated cells with the capacity
to proliferate,self maintain,produce signiﬁcant quantities of
differentiated progeny (i.e., mammary milk-secretory cells),
re-establish tissue function after wounding or maintain the
diversityinallfouroftheseoptions.Thusfar,veryfewreports
have illustrated the location of stem cells in epithelial organs.
Nevertheless, a model has been proposed [7] that suggests
transit cells share similar replication and regenerative capac-
ities with stem cells, but differ in their ability to acquire one
or more differentiation markers [7].
In mice, the development of the mammary gland is
orchestrated by a process of ductal branching that begins
in utero, ceases at birth, and is then reestablished at puberty
[8–12]. Following several hours post-puberty, a large bul-
bous invasive structure,the terminal end bud (TEB),located
at the tip of the mammary duct, can be observed [11]. Sev-
eral groups have demonstrated that the movement, develop-
ment,and shape of the TEB are inﬂuenced by systemic ovar-
ian hormones, local cytokine stimulus, and other molecules
[11–14]. Epithelial cell types that comprise the mammary
duct or TEB have been identiﬁed through immunohisto-
chemical and ultrastructure analysis [4,12,15,16]. However,
since these observations, only few reports have attempted
manipulative or molecular studies to determine the loca-
tion or expression of cells directly involved in the develop-
ment of TEBs, ducts or microbreast lesions [13, 17–20]. The
focus of this study was to locate stem cells by identifying
them as long-lived, label-retaining mammary epithelial cells
(LRCs) in TEBs,and/or mammary ducts. This study was also
undertaken to assess possible, differences in gene products
between LRCs and other types of epithelial cells that form
the duct. To accomplish this, a ﬂuorescent labeling method
wasdevelopedthatpulselabelsindividualprimarymammary
epithelial cells with ﬂuorescent TRITC-cell linker membrane
label and BrdU. The labeled cells were transferred into the
cleared mammary fat pads of syngeneic mice and held for 5
and 8weeks before examining the position of label-retaining
cells.We further probed for cell-cell junctional complexes α-
cateninandZonulaOccluden-1(ZO-1)andthemilkproteins
β-caseinandwheyacidicprotein(WAP)todetermineifthese
geneproductsareimportantintermediariesinestablishingan
elaborate communication link between LRCs and other cells
of the TEB and/or duct [21–24].
The results from these experiments indicate that LRCs
are stem cells and progeny from these cells are arranged as
transitionalunits(TUs)whichcanbelocatedinterminalend
buds200–600µmindiameterorevery250±75µminducts.
MATERIALS AND METHODS
Animals
Brieﬂy, a total one hundred mice were used for the en-
tire experiment (50 FVB/N and 50 C57 Bl6N) (NCI/FCRDC,134 Nicholas J. Kenney et al. 1:3 (2001)
Fredrick,MD).Twenty13week-oldmicewereusedfortrans-
plantation recipients. Recipients were cleared of the host’s
mammaryepitheliumpriortotransplantation[3,10,17,42].
Hosts were sacriﬁced at estrous by staging vaginal smears
every four days [20].
Pulse-labelingandtransplantation
For in vitro TLC labeling; TLC pulse labeled HC-11 cells
were pulsed at 1 × 106 cells with TLC label (2 × 10−6 M
of PKH26-GL) for 3min and either plated in three 96 well
platesorseededonto4wellplasticchamberslides(NuncInc,
Naperville, IL). HC-11 cells were grown from 10–28days in
culture as previously described [26]. Cells were then ﬁxed in
4%paraformaldehydeandcounterstainedwithmethylgreen.
To pulse label mammary primary cultures with the ﬂu-
orescent membrane marker, twenty 13week-old mammary
glands from either C57 Bl 6 or FVB/N mice were excised,
collagenase digested (1mg/ml, Sigma) for 12hi ns e r u m
free media plus DMEM/F12 [17, 42]. The primary culture
was then centrifuged and resuspended into single cells. Flu-
orescent pulse labeling required pulsing single mammary
epithelial cell and carrier inoculum (mammary ﬁbroblasts
at 1×105) with TLC label (2×10−6 M of PKH26-GL,Sigma
Biosciences) in cell linker diluent (Diluent C) for 3min [27].
Thereactionwasthenstoppedwith2%FBScentrifugedtwice
and resuspended in serum free DMEM/F12 and prepared for
transplantation. Transplantation of 1 × 104 of pulsed mam-
mary cells and ﬁbroblast carrier inoculum was carried out as
previously described [10, 17, 19]. Brieﬂy, TLC labeled mam-
mary cells were inoculated into the #4 inguinal mammary
gland and nonlabeled mammary/ﬁbroblasts were inoculated
into the contralateral inguinal mammary gland. Mammary
glands were previously cleared of the host’s epithelium prior
to transplantation. 5-Bromodeoxyuridine (BrdU) labeling of
S-phasemammarycellswascarried 30minposttransplanta-
tion by supplying animals with 600mg/ml BrdU in drinking
water ad labium for 5days [26].
Immunohistochemistryandimmunoﬂuorescence
Mammary glands were collected by removing the entire
#4 inguinal gland, ﬂoated in OCT medium and allowed to
freeze to −70◦C. Mammary sections were sectioned from 7–
20µmandairdriedinthedarkfor 4h.Sectionswereblocked
for 2h at room temperature (rt). Anti-rat-BrdU (diluted at
1:50, Sigma Biosciences) was incubated with mammary sec-
tionsat 4◦C overnight.Washes in PBS were performed over a
30min period involving at least 3 changes. Tissue sections
were then incubated with biotinylated rabbit-anti-rat IgG
(SigmaBiosciences) 2–3hatrt.Sectionswerevisualizedwith
DAB(VectorLabs,Burlingame,CA)andcounterstainedwith
methyl green as previously described [17,19].
Immunoﬂuorescence was carried out in mouse mam-
mary glands by removing the entire inguinal gland, stored
in OCT medium and allowed to freeze to −70◦C. Mam-
mary sections were then sectioned and reacted with 5%
blocking buffer for 1h at rt. Sections were then incu-
bated with either mouse monoclonal α-catenin (diluted at
1:1000) (Transduction Labs, Lexington, KY), mouse mon-
oclonal β-catenin (diluted at 1:500) (Transduction Labs,
Lexington, KY), mouse monoclonal E-cadherin (diluted at
1:1000) (Transduction Labs, Lexington, KY), rabbit anti-
mouse casein (diluted at 1:250, kindly provided by Dr G.
H. Smith, NCI, NIH) rabbit anti-mouse WAP (diluted at
1:50,kindlyprovidedbyDrL.Hennighausen,NIDDK,NIH),
or rabbit anti-human ZO-1 (diluted at 1:250) (Zymed Labs,
San Francisco,CA). Following primary antibody incubation,
ﬂuorescent secondary antibodies anti-rabbit AMCA (1:250,
Molecular Probes, Eugene, OR) or anti-mouse FITC (1:50,
Boehringer Mannheim, Indianapolis, IN), were carried out
at 4◦C in the dark. After three washes in PBS,mammary sec-
tions were later counterstained with methyl green, mounted
and subjected to confocal laser scanning microscopy.
Insituhybridization
Bright ﬁeld in situ hybridization of OCT-embedded
mammary sections were performed as described by Bri-
etshopf et al. [25] and Friedmann et al. [28], using sin-
gle stranded digoxingen-UTP labeled RNA probes (Genius
4/RNA Labeling Kit) (Boehringer Mannheim, Indianapolis,
IN). Mammary sections were digested with 20µg/ml pro-
teinase K for 30min [25], washed in PBS twice and blocked
for 2h at rt with 10% blocking serum/PBS. Digoxigenin-
labeled RNA probes were prepared and isolated accord-
ing to Friedmann et al. [28] and kit protocols (Boehringer
Mannheim, Indianapolis, IN). The mouse α-catenin 3.45kb
Bam HI-EcoR I, mouse β-catenin 2.4kb Kpn I-Bam HI,
and mouse E-cadherin 2.52kb Bam HI-EcoRI riboprobes
were kindly provided by Dr O. Blashuck (McGill University,
Montreal, Canada) and Dr L. Rimm (Yale University, New
Haven, CT). Overnight incubation with hybridization mix
was performed without rocking at 65◦C. After rinsing with
buffers[25]slideswereincubatedwithanti-digoxigeninalka-
line phosphatase (Boehringer Mannheim, Indianapolis, IN)
visualized with NBT-BCIP (Sigma Biosciences), and coun-
terstained with methyl green. Photographs were taken on an
Olympus AH-2 Vanox-S microscope using NIH Image and
transferred to a Macintosh Power Station. Images were fur-
ther processed using Adobe Photoshop Software.
In situ hybridization of ﬂuorescent labeled outgrowth
were prepared the same as bright ﬁeld image with the fol-
lowing modiﬁcations. Tissue sections were air dried for 4h
in the dark and digested with 20µg/ml proteinase K/PBS
for 30min. Sections were then blocked with 10% sheep
serum in PBS (1h) before adding the hybridization mix.
Hybridizations were carried out at 63◦C overnight in the
dark. After rinsing with buffers [25] and tissue reacted with
anti-digoxigenin FITC (Boehringer Mannheim, Indianapo-
lis, IN), mammary sections were washed with PBS, mounted
in mounting medium and prepared for confocal laser
microscopy.
Confocalscanninglasermicroscopy
TLC pulse labeled, in situ and/or immunostained mam-
mary sections were examined with a Zeiss Axiovert 1351:3 (2001) Stem cells in the mouse mammary duct in vivo 135
ConfocalLaserScanningMicroscopeequippedwitha15mW
Krypton-argon laser. Images were collected using a 20x or
40x ﬂuorochrome immersion lens and were Kalmon ﬁltered.
The pinhole aperture was adjusted to the minimum setting
in order to optimize z-axis resolution. In cases where in situ
and immunostainable images were visualized, dual images
using one ﬂuorescent and one substage ﬁber optic device to
detect another ﬂuorescent channel was used. 3D laser sec-
tioning consisted of 15–25 horizontal sections (X-Y) from
7–20µm cut mammary sections and processed using Zeiss
Image software. Patch size and intensity ratio were calculated
by outlining each TLC labeled cell using NIH Image. In all
specimens (tissue culture and tissue sections),the amount of
TLC label intensity was categorized as either (+) dull (over
25%background),(++)mild(between40%–60%overback-
ground) or (+++) bright (above 70% background). Images
werethentransferredtoMacintoshPowerStationwherethey
were processed using Adobe Photoshop Software.
Scoring
Cellpositivitywasscoredbythefollowingmethod,atotal
of 5 random ﬁelds from each section were used for scoring.
All ﬁelds that were scored contained more than 100 cells.
The percentage of stained cells (positive cells stained brown
or purple over green negatively stained cells) was calculated
by dividing the number of stained cells by the total number
of cells counted as previously described [17, 19]. The results
from each ﬁeld were compared using a two-way analysis of
variance.
RESULTS
Pulse-labelingofmammaryepithelialcellsinvitro
In order to identify the location of stem cells as long-
lived label-retaining mammary epithelial cells (LRCs) in the
mammary duct in vivo, BrdU [29] and BKH26-GL [26],
were utilized as tracking markers. PKH26-GL is a ﬂuorescent
cell linker compound (Excitation max = 551nm, Emission
max = 587) that incorporates aliphatic reporter molecules
into the cell membrane by selective partitioning [26]. The
cells can be visualized under the TRITC channel during im-
munoﬂuorescence of confocal microscopy. The technology
hasbeenlimitedtoanumberof modelsystemsinvitroandin
vivo. The half-life of elution of PKH26 from rabbit red blood
cellsisgreaterthan 100daysinvivo.Labeledcellsusuallyvary
frombrightanduniformlabelingtoapunctuateorpatchyap-
pearance.Inaddition,thelabelingisnotasaturationreaction
but a function of both dye and cell concentration, therefore
2x10-6M of linker was used in the experiment. Over-labeling
of the cells would result in loss of membrane integrity and
cell recovery. We have also evaluated the uniformity of stain-
ing,cell viability (by propidium staining),and the coefﬁcient
of variation of ﬂuorescent peaks to maximize the optimum
dye/cell kinetics [26, 29]. Initially, TRITC-cell linker labeled
cells(TLC)wereexaminedforlabelingpotential invitrowith
the nontransformed immortalized mouse mammary epithe-
lialHC-11cellline.Cellswerepulsedfor 3minwithTLCand
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Figure 1: Graph depicting the number of divisions HC-11 cells un-
dergowhilelosingTLClabel.Incellsthatreached 5±1generations,
over 80% of TLC label was lost. HC-11 cell morphologies () and
C57BL/6N mouse primary epithelial cultures () that were scanned
for ﬂuorescent intensities and grown according to materials and
methods. Inset, bright TLC labeled stem cell surrounded by differ-
entiated progeny using IF (A), phase contrast (B) and bright ﬁeld
microscopy (C). Arrow in (C) represents pale counterstained stem
cell. (D), Differentiated cell and its nearby differentiated daughter
cell. (E), One of 4 differentiated HC-11 morphologies that can be
labeled using the TRITC cell linker. Scale bars (A–E) 15µm.
grownassinglecellsin96wellplatesfor 5days.Followingcell
ﬁxation and histological counterstaining, the number of cell
divisionswhichisinverselyproportionaltoﬂuorescentsignal
was calculated using the image-based format developed by
NIH Image. The data suggests that following the ﬁrst 24h
of growth, cells lose 40% ± 10% of TLC signal after their ﬁrst
cell division (Figure 1). Following the second cell division,
HC-11 cells lose an additional 20% of label until reaching
basal levels (6–7 cell divisions) (P>0.05). Similar results
were also observed in pulse-labeled mammary epithelial pri-
mary cultures established from female FVB mice (Figure 1).
The results suggest that the TLC method can be used to track
the number of cell divisions in both mammary cell lines and
mammary cell cultures in vitro.
Thelocationoflong-livedlabel-retainingcells
inTEBsanddevelopingducts
The location of LRCs in the mammary duct in vivo was
assessed by two methods; ﬁrst by transplanting TLC pulsed-
labeled primary mammary epithelial cells into the cleared
mammary fat pads of syngeneic hosts and second, immedi-
ately following surgery, animals were given BrdU ad labium
for 5days [29]. Hosts that received transplants were held for
either 5weeks to identify long-lived LRCs in TEBs or 8weeks
to identify the location of these cells in ducts. The initial
results suggest that TLC-LRCs are located in the midductal136 Nicholas J. Kenney et al. 1:3 (2001)
Table 1: Expression of cell-cell molecules located in nonlabeled or pulse-labeled mammary glands.
Nonlabeled glands
Pulse-labeled outgrowths∗
Dull Mild Bright
mRNA % positive
α-catenin 49 ± 43 1 ± 10 42 ± 39 8 ± 1
β-catenin 69 ± 25 1 ± 26 50 ± 75 0 ± 7
E-cadherin 54 ± 44 6 ± 54 7 ± 10 50 ± 7
Protein % positive
α-catenin 19 ± 42 2 ± 14 1 ± 87 5 ± 13
β-catenin 40 ± 64 2 ± 64 1 ± 42 7 ± 6
E-cadherin 47 ± 44 5 ± 74 5 ± 41 9 ± 2
β-casein 50 ± 74 6 ± 32 0 ± 3
WAP 20 ± 32 5 ± 2 E/N
ZO-1 33 ± 35 0 ± 29 1 ± 8
E/N represents expression near a bright TLC-LRC.
∗LRC patch size and intensity ratio were calculated by outlining each BrdU or TLC labeled cell using NIH Image. LRC patch size equaled
7.5µm2. Observations were generated by examining 5 random ﬁelds from C57Bl6N or FVB/N mammary sections. The amount of BrdU
or TLC label intensity was categorized as either (+) dull (over 25% background at 4–8 cell divisions after initial pulse), (++) mild (between
40%–60% over background at 2–4 cell divisions after initial pulse) or (+++) bright (above 70% background at 1–2 cell divisions after initial
pulse).
region, subtending, at the tip of the mammary duct and in
the TEB. In each of these areas, a signiﬁcant percentage of
bright TLC-LRCs were detected [50%, P<0.001]( T a b l e1 ) .
Localization of bright BrdU-LRCs were also located in the
same areas suggesting LRCs are positioned at distinct sites in
the mammary gland. However, in several pulse-labeled out-
growth,several mammary ducts also failed to stain for either
TLC or BrdU label (photomicrographs not shown). The ex-
planation for these phenomena is unknown.
ArrangementofLRCsinTEBsanddevelopingducts
To examine the arrangement of LRCs along the mam-
mary duct, portions of 5week-old ducts and TEBs were ass-
essed using 3-dimensional (3D) confocal microscopy. The
results suggest that bright TLC-LRCs were detected at the
tip of the TEB, and in areas of the subtending duct (Figure
2). Interestingly, TLC-LRCs also appeared to be grouped as
aggregates or transitional units (TUs) (Figure 2 arrow). We
further examined these units by 3D montage photography
and determined that within the TU at least one bright LRC is
usuallyincontactwithanotherLRCbylongthinprocessesre-
ferredtoascytonemes(photomicrographsnotshown).Cyto-
nemes,cellularprocessesthatmayspanseveralcelldiameters
have been implicated in dispersing signaling proteins such as
Hedgehog (Hh), Decapentaplegic (Dpp) and Wingless dur-
ingDrosophilaimaginaldiscdevelopmentorchicklimb-bud
development.
Wealsodeterminedby3Dimaginary,the3Darrangement
of the TU. The transitional unit is comprised of LRCs at least
3 cells across and at least 3 cells deep (Figure 2). In addition,
LRCs within the TU were also semi-quantiated to determine
the number of cell divisions of each cell (cell history) in the
unit. A total of 5 TUs (n>10 cells) were examined. The
data suggests that while LRCs within the TU retain signiﬁ-
cant levels of label above 68% (P<0.001), cells outside the
unit have signiﬁcantly lower ﬂuorescent label (near or be-
low 33%) (P<0.01). These data suggest that TUs contain
stem cells and their progeny along various locations of the
mammary duct.
Transitionalunitsandthelocationofcelladhesion
moleculesinnormalmammaryglands
Stemcellsdependuponcell-cellcommunicationinorder
to undergo division [7]. Important intermediaries in this
process are cell adhesion molecules such as α-catenin, E-
cadherin,andZO-1[21,22,30].Toaccessthelocationofthese
molecules immunohistochemistry and in situ Hybridization
werecarriedoutinintactnonlabeledmammaryglands.Upon
examining differences in α-catenin expression in 6week-old
glands, approximately 49% of ductal epithelium expressed
this gene (Figure 3A) (Table 1). Luminal cells arranged
as transitional units in the TEB also expressed α-catenin
mRNA (Figure 3A). α-catenin protein was also expressed
in 6week-oldglands,butatverylowlevels(19%)(Figures3B
and 3C) (Table 1).
Further, β-catenin mRNA was detected in 69% of ductal
epithelium in 6week-old glands (Figure 3D) (Table 1).Adja-
cent stroma also expressed β-catenin mRNA. At the protein
level, β-catenin was detected in the TEB (42%) but not in
the outermost cell layer of the mammary duct which contain
myoepithelialcells(Figure3E)(Table1).Asimilarexpression
pattern was also observed in aged 10week-old ducts (data
not shown).
E-cadherin mRNA was also detected in 47% of ductal
cells from 6week-old glands (Figure 3F) (Table 1). Stroma
adjacent to ducts also expressed E-cadherin mRNA and1:3 (2001) Stem cells in the mouse mammary duct in vivo 137
(A)
(B)
Figure2:Confocal3Dmicroscopicimageof brightTRITClabeled-
retainingcellsin 5week-oldFVB/NTEB.(A)3Dmicroscopicimage
of bright TRITC labeled-retaining cells. Note the location of bright
LRCsandaTUs(arrow).(B)Lasersectionsrepresentenfaceviewsof
serial sections that were recorded at 0.7µm intervals. Three dimen-
sionalimageandopticalserialsectionsweregeneratedandprocessed
according to materials and methods. Scale bars in (A), (B) 260µm.
E-cadherin protein but was not detected in the myoepithe-
lium of the TEB (Figures 3F, 3G, and 3H) (Table 1).
Celladhesionexpressioninpulsed-labeled
mammaryglands
The next set of experiments determined if cell adhesion
molecules were associated with label-retaining stem cells by
identifying these cells under immunoﬂuorescence,immuno-
histochemistry, in situ Hybridization (ISH) or ﬂuorescent in
situHybridization(FISH).Theresultssuggestthat,α-catenin
mRNA colocalized with 98% (P<0.001) of brightly stained
BrdU-LRCs cells which were positioned along the end bud
(Figures 4A and 4B, Table 1). In comparison to nonlabeled
mammary ducts, α-catenin mRNA was also detected in 40%
(P<0.01) of labeled ductal cells. In addition, the α-catenin
proteinwasdetectedin75%±2%(P<0.001)oftheepithelial
cellsoftheTEBwhichclearlyassociatedwithTUs(Figures4A
and 4B) (Table 1,photomicrographs not shown). There were
nosigniﬁcantcorrelationsbetweenβ-cateninandE-cadherin
expression with TUs or LRCs (P<0.01)(T a b l e1 ) .H o w e v e r ,
ZO-1 immunostaining was detected in 91% (P<0.001)o f
the bright LRCs (Figures 5A and 5B) but was not as signiﬁ-
cant as α-catenin (P<0.01) (photomicrographs not shown
and summarized in Table 1).
Finally, to determine if the differentiation markers β-
casein and WAP [23, 24] are expressed in LRCs, we collected
8week-old samples obtained at estrous. The results indicate
that at least 20% of the epithelial cells express either β-casein
or WAP proteins. However, localization of these proteins to
bright TLC LRCs was not observed (P>0.05)(T a b l e1 ,p h o -
tomicrographs not shown).
AnatomicalpositionanddistancesofTUsalong
developingandagedmammaryducts
To determine the abundance, location, and distances of
LRCs and TUs along the mammary duct, sections from both
intact and transplanted mammary glands were examined.
The procedure involved examining 60 ducts from mammary
glands (n>30) in C57Bl6 or FVB/N mice according to the
materials and methods. The results suggest LRCs are sparsely
locatedthroughouttheductorTEB(Table2).However,ducts
100–400µminlengthorTEBs200–600µmindiameterhold
up to at least 2 TUs on either axis of the structure. In addi-
tion, we could not detect TUs in secretory lobule structures
collected from virgin glands. These data are summarized in
Table 2.
DISCUSSION
Despitetheextensiveknowledgeofmoleculesthatcanpo-
tentiallyregulateaberrantbreastcancergrowthorthedetailed
morphology-histology analysis of normal mammary devel-
opment,theexactlocationof stemcellsthatcancontributeto
theformationandmaintenanceofthemammaryductremain
obscure [6]. This is due in part to the failure of attempting to
identify the location of single stem cells.
Thetransplantationapproachisavalidapproachtodeter-
mine stem cell location. The transplantation of mammary
epithelial cells into syngeneic mice recapitulates exactly the
morphogenetic processes observed in intact animals and has
been described by many Mammary Gland Biologists over
40years (see [12]). In this study, we sought to investigate
three different aspects never before determined in the mouse
mammary gland. The ﬁrst, was to devise a calorimetric mi-
croscopy assay to visualize mammary epithelial stem cells in
vitro. This assay involved utilizing a ﬂuorescent tracking die
that effectively couples to the membrane of single cells dis-
persed in culture. The method has been used to label stem
cells such as precursor hemopoetic cells in situ (Horan et al.
[30])andwasmodiﬁedtolabelinvitro,animmortalizednon-
transformedmammaryepithelialcellline(HC-11)knownto138 Nicholas J. Kenney et al. 1:3 (2001)
(A) (D) (F)
(B) (C) (E) (G) (H)
Figure 3: α-catenin, β-catenin, and E-cadherin expression in 6week-old mammary glands. (A) Mammary section hybridized with
digoxigenin-UTP-labeled probe for α-catenin mRNA. Note in end bud tip (ebt), ﬁbroblasts (f), and luminal epithelium (le) express α-
catenin. (B–C)Association of α-catenin protein expression and transitional unit (boxed areas) in the TEB. Note in (C), α-catenin expressing
cellandcytoneme.(D)6week-oldmammarysectionhybridizedwithdigoxigenin-UTP-labeledprobeforβ-cateninmRNA.(E)β-cateninim-
munostainingoutlinestheluminalepithelialcelllayerof the 6week-oldTEB.(F) 6week-oldmammarysectionhybridizedwithdigoxigenin-
UTP-labeled probe for E-cadherin mRNA. (G–H) E-cadherin immunostaining in 6week-old glands. Note E-cadherin expression outlines
the luminal epithelial cell layer of the 6week-old TEB, but negative staining occurs in the transitional unit (boxed area). All sections were
collected according to materials and methods. Insets in (A–B, D–G) control probed tissue, respectively. Scale bars (A–B) 50µm, (C) 24µm,
(D–E) 50µm, (F–G) 50µm, and (H) 24µm.
possessubpopulationsofmammarystemcells.Afterlabeling,
single cells were seeded into 96 well plates and the morphol-
ogy, ﬂuorescent intensity, and ontogeny were recorded over
time. The in vitro data yielded signiﬁcant results. We deter-
mined that ﬂuorescent label was lost in all differentiated cells
aftereachsuccessivedivisionbutwasnotretainedincellsthat
underwent infrequent cell division. Upon examining these
cells after counterstaining with methyl green these cells did
not retain counterstain, exhibited stem cell-like morpholo-
gies (Smith et al. [16]), and gave rise to 4 different HC-11
cell morphologies over time (see inset Figure 1). The results
suggest that we have established a ﬂuorescent based assay
that can label and distinguish between mammary epithe-
lial stem cells and mammary epithelial differentiated cells
in vitro. Continuing, the second aspect was to develop a mi-
croscopic assay that can determine the location of mammary
epithelial stem cells using both light microscopy and ﬂuo-
rescent. The principle of the double-labeling assay rests on
the transplantation of ﬂuorescent-labeled single cells into
cleared syngeneic fat pads and following post-surgery, ani-
mals are pulsed-labeled with BrdU for 5days and chased for
5 to 8weeks. The predication behind this postulate is the un-
derstanding that as the transplanted cells begin to develop
mammary ducts, massive cell division, terminal differenti-
ation, migration, selection, apoptosis, or ankois are taking
place as early as day 1 of transplantation and cease around
8weeks post-transplantation. During these periods, within
eachmammaryduct,cellseclusion,orcellsthatareprotected
fromtheseenvironmentsretainlabelandarethereforeeasyto
dissociate under bright ﬁeld microscopy (in the case of BrdU
positivity) or under ﬂuorescence (in the case of TRITC label-
ing). We have found that both tracers are easy to distinguish
under the microscope and were located in similar glandu-
lar locations suggesting label-retaining mammary epithelial
stem cells can be detected in vivo. The ﬁnal aspect of this
study was to describe the 3-dimensional landscape in which
label-retaining mammary epithelial stem cells are located in
the mammary duct. These observations would determine if
mammary epithelial stem cells are situated in cell arrange-
ments similar to the crypts of the intestine,integument,liver,
or lung. We report that confocal 3-dimensional montage
images of mammary epithelial cells are arranged within a
cluster of differentiated cells or “transitional unit” and that
these units are spatially spread throughout various areas of
growingandoragedmammaryducts.Thereareanumberof
knowncaveatsinvivoandinvitroof whylabel-retainingcells1:3 (2001) Stem cells in the mouse mammary duct in vivo 139
(A) (B)
Figure 4: Colocalization of α-catenin mRNA, protein and BrdU/TLC positivity in 8week-old C57 Bl6N aged mammary duct. (A–B)
Detection of α-catenin mRNA (blue) and BrdU immunostaining (brown) in mammary ducts hybridized to a digoxigenin-UTP labeled
α-catenin probe. (B) Area highlighted in (A) (arrow) under high magniﬁcation. Note brightly stained BrdU cells are arranged as TUs and
appear to be located just proximal to the subtending duct. Inset in (B) represents control section for BrdU staining (secondary antibody
alone). Scale bar in (A), 660µm, and (B), 260µm.
(A) (B)
Figure 5:Detection of ZO-1 protein and bright TLC-LRCs in the 8week-old C57 Bl6N mammary duct. (A) Co-localization of ZO-1 protein
(blue) and bright LRC (red). (B) High power magniﬁcation of area shown in (A) (arrow). Note bright LRCs and ZO-1 expression around
the polarized cell borders. Upper inset in (B) TRITC-rhodamine channel (red) showing bright TLC-labeled cell (arrow) and lower inset,
AMCA-UV channel showing ZO-1 protein expression. Scale bar in (A) 90µm and (B) 190µm.140 Nicholas J. Kenney et al. 1:3 (2001)
Table 2: Location of LRCs and TUs in various ductal compartments.
Ducts
End bud tip Duct Subtending Lobule
LRC∗ ++ +++ +++ +
TU# + ++ +++ nd
nu − ++ +++ nd
TEB
LRC∗ +++ +++ +++ N/A
TU# + +++ +++ −
nu + +++ +++ −
(+),mild detection,(++),weak detection,(+++),strong detection,(−),no detection
∗summary of bright TLC LRCs only.
#summary of both BrdU-TUs and TLC-TUs.
nd,not detected at this time.
N/A represents no association.
nu, nonlabeled units visualized in normal intact mammary ducts under bright ﬁeld microscopy by hematoxylin and eosin staining.
Observations were analyzed by examining 5 random ﬁelds from C57Bl6N or FVB/N mammary sections that contained either aged terminal
ducts or TEBs according to materials and methods. Fluorescent intensity was calculated by outlining each LRCs using NIH Image. Patch size
equaled 7.5µm2.
appeared in our results. The ﬁrst caveat, infrequent cycling
stem cells is one main ﬁnding. The second, the absence of
normal apoptotic processes by which cells retain label is in
question since cells that developed these outgrowths histo-
logically grew out normal, where found to colocalize BrdU,
counterstained as normal shaped pale cells, and where spa-
tiallylocatedinvariouscompartmentsof theduct.Innormal
syngeneic animals, normal apoptotic processes usually result
innormaloutgrowths.Therefore,wehaveruledoutthispos-
sibility. Third, the checkpoint arrested cells as a source for
label-retaining cells in vivo and in vitro. Checkpoint arrested
cellsarecellsthatfailtoreachthenextcycleincelldivision.If
LRCswerecheckpointdefective,thesecellswouldnotbeable
to divide and provide progeny that contribute to the devel-
opment of the outgrowth. Therefore, we disagree with this
possibility. Finally, terminally differentiated cells as a source
of label-retaining cells in the outgrowths. We agree to an
extent. The in vitro experiments suggested an initial pulse
of the TLC tracking dye to terminally differentiated primary
mammary epithelial cells or HC-11 cells can be visualized
in vitro. However, transplantation of single primary termi-
nally differentiated cells into cleared fat pads results in (a)
terminally differentiated mammary cells that lack the cellu-
lar machinery to give rise to progeny that form a complete
duct (see Daniel et al. [3]), (b) terminally differentiated cells
areenlargedhighlyvacuolateddark-counterstainedcells,and
(c) in the breast, terminally differentiated cells are cells that
have undergone milk-production and therefore would have
been expressing WAP and casein proteins and further,would
have generated outgrowths consisting entirely of secretory
structures (Kordon et al. [24]). Therefore, we have ruled out
this possibility. The results of our present study indicate that
transitional units contain stem cells and play an integral role
in the growth and differentiation of the mammary duct.
Formationofthemammarytree:multidimensional
ductalgrowthandpositioning
The mammary duct is an epithelial structure where
largediscontinuitiesinarchitecturalinformationarespatially
maintained. In adult female mice, the mammary trees from
each of the ten normal mammary glands are anatomically
asymmetrical to one another. However, a number of adja-
cent structures (lobules, alveolus, and lateral buds) are spa-
tially located along the left-right axis of the mammary duct.
Positioning of these structures reﬂect matrix protease pro-
duction, molecules that inﬂuence the direction of newly
forming lateral buds/secretory structures [17, 19, 31–33], or
matrix components that control the conﬁguration of the
developing duct [17, 19, 31–35]. The present study shows
that the cell adhesion molecules α-catenin, β-catenin,and E-
cadherin are spatially expressed in the duct suggesting these
molecules may act as intraductal morphoregulators as well.
However, the shape, direction, and function of the duct may
also reﬂect the potential location of the stem cell compart-
ment and steroid receptor positivity [11]. This was demon-
strated earlier by Hoshino [2], who observed that trans-
planted portions of the mammary duct contain positional
and differential information with a basic repeat. Daniel et al.
[3] followed these ﬁndings and observed that transplanted
normal mammary outgrowths that grew out maximally usu-
ally were the oldest. In addition, outgrowths that displayed
average ductal expansion differed in transplant ability sug-
gesting,pocketsofepithelialproliferationwithinasingleduct
maybe heterogeneous. Subsequently, Smith [36] observed,1:3 (2001) Stem cells in the mouse mammary duct in vivo 141
WAP/ β-casein positive
β-catenin/β-casein positive
E-cadherin/β-catenin positive
α-catenin positive
     Transitional unit 
α-catenin/ZO-1 positive
Terminal End Bud
Mature duct
undifferentiated cap cells
myoepithelium
basal lamina
lumen
luminal epithelium
Figure 6: Model for transitional unit operation within the mammary duct. Shortly after puberty, estrous or nursing, stem cells or transit
cells (yellow) committed to acquire additional differentiation markers are positioned within the unit. Positioning (morphogenic movement)
cell-cell communication (acquisition of differentiation markers), or proliferation requires modulation of α-catenin, β-catenin, ZO-1 or
E-cadherinexpressionandcytonemes(pink).Next,accumulationof differentiationmarkers,β-caseinandE-cadherinareacquired(blueand
gray), and ﬁnally, these cells become active secretory epithelium by expressing differentiation markers such WAP (green).
that within a random population of primary mammary ep-
ithelial cells, there exists at least 1 mammary stem cell per
1000 cells which has the capacity to form a complete mam-
marytree.SincewelocatedTUsevery 250+75µm along the
duct, it is quite possible as long as TUs are available ductal
structures will continue to be transplantable.
Theintricacyofthetransitionalunit
Howcanwesafelyimplythatsuchauniquestructurelike
theTUisnotcomposedentirelyof mammaryepithelialstem
cells? Early investigators have described groups of cells or ag-
gregates as a “patterned ﬁeld” [43] or as Leighton et al. [38]
suggested,“a more speciﬁc biological unit” or “an aggregate
may be a loosely knit, short-lived ecological unit or a super-
cellular living organism a distinct individual.Aggregates may
affect one another in several ways such as adjacent cells pro-
viding part of the physical substrate for the migration of a
cell within the aggregate, or by sharing a common pool of
both substrates and products of metabolism.” In line with
this rationale,previous results have indicated that nodules or
aggregates from X-irradiated intestine from inactivated mo-
saic phosphoglycerate kinase mice (PgK-1b/PgK-1a)gi v eri s e
to PgK-1b or PgK-1a absorptive epithelial, goblet, or entero-
endocrine cells [39]. Reynolds and Weiss [40] also described
that in cultures of embryonic striatum, EGF-induced proli-
feration of single precursor cells give rise to spheres of un-
differentiated cells that later divide into three CNS cell types,
neurons,astrocytes,or oligodentrocytes. In the breast,detec-
tion of clonegenic epithelium has been observed by histolo-
gical assays [4] or by detection of X-chromosome inactiva-
tion, where, for example, the normal mammary tree poten-
tially contains contiguous patches of clonegenic epithelium
[40]. In this context, we suggest that TUs reﬂect groups of142 Nicholas J. Kenney et al. 1:3 (2001)
transit cells with stem cells intermixed among them. Our
major argument is that although transit cells are the direct
progeny of long-lived stem cells, they cannot maintain the
same level of self-maintenance [7]. The main function of
transit cells is to progress to a more mature or differentiated
state by acquiring one or more differentiated markers [7]. In
thebreast,unitsof transitcellsmayoperateataprogrammed
sitealongthemammaryductorTEBbyprovidingproliferat-
ingordifferentiatedprogeny.Controlof theTUismodulated
bybothdifferentiatedcellspositionedproximaltotheunitor
cellular cues housed within cynonemes (Figure 6). Interest-
ingly, units or aggregates depend on α-catenin, E-cadherin
and ZO-1 interactions [29, 41]. Recent data has shown that
when E-cadherin/α-catenin negative PC9 lung carcinoma
cells are transfected with α-N-catenin, single cells arrange
themselves as aggregates; patterns of closed spheres with an
expanded lumen. When these spheres are incubated with
anti-E-cadherin neutralizing antibodies, the spheres com-
pletely dissociate back into single cells [37]. In this study,
a ﬂuorescent labeling method was developed to visualize
mammary stem cells transplanted into syngeneic fat pads.
We also show that α-catenin is expressed in stem cells and
their progeny which together form a stem cell niche or unit
thatisassociatedwithnormaloraberrantbreastgrowth.Fur-
ther examination of these areas using laser micro dissection
is now underway.
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